Adverse left ventricular remodeling incommunity-dwelling older adults predicts incident heart failure and mortality

JACC: Heart Failure

Volumn 2, Issue 5, 2014, Pages 512-522

  Zile, Michael R ^a,b   Gaasch, William H ^c   Patel, Kanan ^d   Aban, Inmaculada B ^d   Ahmed, Ali ^d,e  

^a MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

^b RALPH H JOHNSON VA MEDICAL CENTER   (United States)

^c LAHEY HOSPITAL AND MEDICAL CENTER   (United States)

^d UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

^e BIRMINGHAM VA MEDICAL CENTER   (United States)

Author keywords

Heart failure; Left ventricle; Structural remodeling

Indexed keywords

AGED; ARTICLE; CARDIOVASCULAR RISK; CHRONIC KIDNEY DISEASE; COMMUNITY LIVING; CONTROLLED STUDY; DIABETES MELLITUS; DISEASE ASSOCIATION; ECHOCARDIOGRAPHY; FEMALE; FOLLOW UP; HEART EJECTION FRACTION; HEART FAILURE; HEART INFARCTION; HEART LEFT VENTRICLE HYPERTROPHY; HEART LEFT VENTRICLE MASS; HEART LEFT VENTRICLE VOLUME; HEART VENTRICLE REMODELING; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; MORTALITY; PROGNOSIS; ECHOGRAPHY; HEART VENTRICLE; HYPERTROPHY, LEFT VENTRICULAR; INCIDENCE; MYOCARDIAL INFARCTION; RENAL INSUFFICIENCY, CHRONIC; VERY ELDERLY;

AGED; AGED, 80 AND OVER; FEMALE; HEART FAILURE; HEART VENTRICLES; HUMANS; HYPERTENSION; HYPERTROPHY, LEFT VENTRICULAR; INCIDENCE; MALE; MYOCARDIAL INFARCTION; PROGNOSIS; RENAL INSUFFICIENCY, CHRONIC; VENTRICULAR REMODELING;

EID: 84908075392     PISSN: 22131779     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jchf.2014.03.016     Document Type: Article

References (30)

1. Cohn J.N., Ferarri R., Sharpe N. Cardiac remodeling-concepts and clinical implications: a consensus paper from an international forum on cardiac remodeling. JAm Coll Cardiol 2000, 35:569-582.
2. Linzbach A.J. Heart failure from the point of view of quantitative anatomy. Am J Cardiol 1960, 5:370-382.
3. Gaasch W.H., Zile M.R. Left ventricular structural remodeling in health and disease: with special emphasis on volume, mass and geometry. JAm Coll Cardiol 2011, 58:1733-1740.
4. Fried L.P., Borhani N.O., Enright P., et al. The cardiovascular health study: design and rational. Ann Epidemiol 1991, 1:263-276.
5. Levy D., Anderson K.M., Savage D.D., Balkus S.A., Kannel W.B., Caselli W.P. Risk of ventricular arrhythmias in left ventricular hypertrophy: the Framingham Heart Study. Am J Cardiol 1987, 60:560-565.
6. Vasan R.S., Larson M.G., Benjamin E.J., Evans J.C., Levy D. Left ventricular dilation and the risk of congestive heart failure in people without myocardialinfarction. NEngl J Med 1997, 336:1350-1355.
7. Feigenbaum H. Echocardiography 1994, Lea & Febiger, Philadelphia. 5th Edition.
8. Lang R.M., Bierig M., Devereux R.B., et al. Recommendations for chamber quantification: a report from the American Society of Echocardiography's Guidelines and Standards Committee and the Chamber Quantification Writing Group, developed in conjunction with the European Association of Echocardiography, a branch of the European Society of Cardiology. JAm Soc Echocardiogr 2005, 18:1440-1463.
9. Gottdiener J.S., Arnold A.M., Aurigemma G.P., et al. Predictors of congestive heart failure in the elderly: the Cardiovascular Health Study. JAm Coll Cardiol 2000, 35:1628-1637.
10. Verma A., Meris A., Skali H., et al. Prognostic implications of left ventricular mass and geometry following myocardial infarction: the VALIANT (Valsartan in acute myocardial infarction) echocardiographic study. JAm Coll Cardiol Img 2008, 1:582-591.
11. Udelson J.E., Konstam M.A. Ventricular remodeling fundamental to the progression (and regression) of heart failure. JAm Coll Cardiol 2011, 57:1477-1479.
12. Konstam M.A., Kramer D.G., Patel A.R., Maron M.S., Udelson J.E. Left ventricular remodeling in heart failure: current concepts in clinical significance and assessment. JAm Coll Cardiol Img 2011, 4:98-108.
13. Kramer D.G., Trikalinos T.A., Kent D.M., Antonopoulos G.V., Konstam M.A., Udelson J.E. Quantitative evaluation of drug or device effects on ventricular remodeling as predictors of therapeutic effects on mortality in patients with heart failure and reduced ejection fraction: a meta-analytic approach. JAm Coll Cardiol 2010, 56:392-406.
14. Desai R.V., Ahmed M.I., Mujib M., Aban I.B., Zile M.R., Ahmed A. Natural history of concentric left ventricular geometry in community-dwelling older adults without heart failure during seven years of follow-up. Am J Cardiol 2011, 107:321-324.
15. Zile M.R., Gottdiener J.S., Hetzel S.J., et al. Prevalence and significance of alterations in cardiac structure and function in patients with heart failure and a preserved ejection fraction. Circulation 2011, 124:2491-2501.
16. Ganau A., Devereux R.B., Roman M.J., et al. Patterns of left ventricular hypertrophy and geometric remodeling in essential hypertension. JAm Coll Cardiol 1992, 19:1550-1558.
17. Koren M.J., Devereux R.B., Casale P.N., Savage D.D., Laragh J.H. Relation of left ventricular mass and geometry to morbidity and mortality in uncomplicated essential hypertension. Ann Intern Med 1991, 114:345-352.
18. Verdecchia P., Schillaci G., Borgioni C., et al. Adverse prognostic significance of concentric remodeling of the left ventricle in hypertensive patients with normal left ventricular mass. JAm Coll Cardiol 1995, 25:871-878.
19. Krumholz H.M., Larson M., Levy D. Prognosis of left ventricular geometric patterns in the Framingham Heart Study. JAm Coll Cardiol 1995, 25:879-884.
20. Milani R.V., Lavie C.J., Mehra M.R., Ventura H.O., Kurtz J.D., Messerli F.H. Left ventricular geometry and survival in patients with normal left ventricular ejection fraction. Am J Cardiol 2006, 97:959-963.
21. Grossman W., Jones D., McLaurin L. Wall stress and patterns of hypertrophy in the human left ventricle. JClin Invest 1975, 56:56-64.
22. Quinones M.A., Gaasch W.H., Cole J.S., Alexander J.K. Echocardiographic determination of left ventricular stress-velocity relations in man: with reference to the effects of loading and contractility. Circulation 1975, 51:689-700.
23. Dumesnil J.G., Shoucri R.M. Effect of the geometry of the left ventricle on the calculation of the ejection fraction. Circulation 1982, 65:91-98.
24. Hill J.A., Karami M., Kutschke W., et al. Cardiac hypertrophy is not a required compensatory response to short-term pressure overload. Circulation 2000, 101:2863-2869.
25. Esposito G., Rapacciuolo A., Nagaprasad S.V., et al. Genetic alterations that inhibit invivo pressure-overload hypertrophy prevent cardiac dysfunction despite increased wall stress. Circulation 2002, 105:85-92.
26. Kupari M., Turto H., Lommi J. Left ventricular hypertrophy in aortic valve stenosis: preventive or promotive of systolic dysfunction and heart failure. Eur Heart J 2005, 26:1790-1796.
27. Orsinelli D.A., Aurigemma G.P., Battista S., Krendel S., Gaasch W.H. Left ventricular hypertrophy and mortality after aortic valve replacement for aortic stenosis. A high risk subgroup identified by preoperative relative wall thickness. JAm Coll Cardiol 1993, 22:1679-1683.
28. Cioffi G., Faggiano P., Vizzardi E., et al. Prognostic effect of inappropriately high left ventricular mass in asymptomatic severe aortic stenosis. Heart 2011, 97:301-307.
29. Mor-Avi V., Jenkins C., Kuhl H.P., et al. Real-time 3-dimensional echocardiographic quantification of left ventricular volumes: multicenter study for validation with magnetic resonance imaging and investigation of sources of error. JAm Coll Cardiol Cardiovasc Img 2008, 1:413-423.
30. Chuang M.L., Gona P., Hautvast G.L.T.F., Salton C.J., Blease S.J., Yeon S.B., et al. Correlation of trabeculae and papillary muscles with clinical and cardiac characteristics and impact on CMR measures of LV anatomy and function. JAm Coll Cardiol Img 2012, 5:1115-1123.